drugset / Trial / NCT01590836
A Trial Investigating the Pharmacodynamic Properties of NN5401 in Subjects With Type 1 Diabetes
Non-randomizedSingle-groupOpen-labelTreatment
Summary
This trial is conducted in Europe. The aim of this trial is to investigate the pharmacodynamic response (the effect of the investigated drug on the body) of insulin degludec/insulin aspart (IDegAsp) at steady state in subjects with type 1 diabetes.
Timeline
- Start
- 2012-04
- Primary completion
- 2012-06
- Completion
- 2012-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | insulin aspart | Protein / enzyme biologic | 0.18 iu/kg | Subcutaneous |
| Subject | insulin degludec | Protein / enzyme biologic | 0.42 iu/kg | Subcutaneous |